{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:52:57Z","timestamp":1760233977464,"version":"build-2065373602"},"reference-count":97,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Cell-free DNA (cfDNA) testing, is an emerging \u201cliquid biopsy\u201d tool for noninvasive lymphoma detection, and an increased amount of data are now available to use this technique with accuracy, especially in classical Hodgkin lymphoma (cHL). The advantages of cfDNA include simplicity of repeated blood sample acquisition over time; dynamic, noninvasive, and quantitative analysis; fast turnover time; reasonable cost; and established consistency with results from tumor genomic DNA. cfDNA analysis offers an easy method for genotyping the overall molecular landscape of pediatric and adult cHL and may help in cases of diagnostic difficulties between cHL and other lymphomas. cfDNA levels are correlated with clinical, prognostic, and metabolic features, and may serve as a therapeutic response evaluation tool and as a minimal residual disease (MRD) biomarker in complement to positron emission tomography (PET). Indeed, cfDNA real-time monitoring by fast high-throughput techniques enables the prompt detection of refractory disease or may help to address PET residual hypermetabolic situations during or at the end of treatment. The major recent works presented and described here demonstrated the clinically meaningful applicability of cfDNA testing in diagnostic and theranostic settings, but also in disease risk assessment, therapeutic molecular response, and monitoring of cHL treatments.<\/jats:p>","DOI":"10.3390\/ph14030207","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T10:36:37Z","timestamp":1614681397000},"page":"207","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cell-Free DNA for the Management of Classical Hodgkin Lymphoma"],"prefix":"10.3390","volume":"14","author":[{"given":"Vincent","family":"Camus","sequence":"first","affiliation":[{"name":"Department of Hematology, Centre Henri Becquerel, 76038 Rouen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6804-7943","authenticated-orcid":false,"given":"Fabrice","family":"Jardin","sequence":"additional","affiliation":[{"name":"Department of Hematology, Centre Henri Becquerel, 76038 Rouen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1470-2045(03)01320-2","article-title":"Part II: Hodgkin\u2019s lymphoma--diagnosis and treatment","volume":"5","author":"Diehl","year":"2004","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(18)30784-8","article-title":"PET-Adapted Treatment for Newly Diagnosed Advanced Hodgkin Lymphoma (AHL2011): A Randomised, Multicentre, Non-Inferiority, Phase 3 Study","volume":"20","author":"Casasnovas","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","article-title":"FDG-PET after Two Cycles of Chemotherapy Predicts Treatment Failure and Progression-Free Survival in Hodgkin Lymphoma","volume":"107","author":"Hutchings","year":"2006","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.4.110807.092209","article-title":"Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma","volume":"4","author":"Schmitz","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/cncy.21742","article-title":"Fine-needle aspiration and core needle biopsy: An update on 2 common minimally invasive tissue sampling modalities: FNA Versus CNB","volume":"124","author":"VanderLaan","year":"2016","journal-title":"Cancer Cytopathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3324\/haematol.2016.145102","article-title":"Detection and Prognostic Value of Recurrent Exportin 1 Mutations in Tumor and Cell-Free Circulating DNA of Patients with Classical Hodgkin Lymphoma","volume":"101","author":"Camus","year":"2016","journal-title":"Haematologica"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating Tumor DNA Reveals Genetics, Clonal Evolution, and Residual Disease in Classical Hodgkin Lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/10428194.2018.1492123","article-title":"Somatic Mutations of Cell-Free Circulating DNA Detected by Targeted next-Generation Sequencing and Digital Droplet PCR in Classical Hodgkin Lymphoma","volume":"60","author":"Bessi","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3324\/haematol.2019.237719","article-title":"Targeted Genotyping of Circulating Tumor DNA for Classical Hodgkin Lymphoma Monitoring: A Prospective Study","volume":"106","author":"Camus","year":"2020","journal-title":"Haematologica"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2352-3026(14)00039-8","article-title":"Non-Invasive Detection of Genomic Imbalances in Hodgkin\/Reed-Sternberg Cells in Early and Advanced Stage Hodgkin\u2019s Lymphoma by Sequencing of Circulating Cell-Free DNA: A Technical Proof-of-Principle Study","volume":"2","author":"Vandenberghe","year":"2015","journal-title":"Lancet Haematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/jcb.25456","article-title":"DNA Superresolution Structure of Reed-Sternberg Cells Differs Between Long-Lasting Remission Versus Relapsing Hodgkin\u2019s Lymphoma Patients: DNA Structure In Pre-Treatment Hodgkin\u2019s Lymphoma","volume":"117","author":"Righolt","year":"2016","journal-title":"J. Cell Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1158\/0008-5472.CAN-12-3287","article-title":"Extracellular DNA in Pancreatic Cancer Promotes Cell Invasion and Metastasis","volume":"73","author":"Wen","year":"2013","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1126\/science.148.3668.374","article-title":"Circulating DNA as a Possible Factor in Oncogenesis","volume":"148","author":"Bendich","year":"1965","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: Genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lowes, L.E., Bratman, S.V., Dittamore, R., Done, S., Kelley, S.O., Mai, S., Morin, R.D., Wyatt, A.W., and Allan, A.L. (2016). Circulating Tumor Cells (CTC) and Cell-Free DNA (CfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091505"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm.3915","article-title":"Toward Understanding and Exploiting Tumor Heterogeneity","volume":"21","author":"Alizadeh","year":"2015","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0009-8981(01)00665-9","article-title":"About the possible origin and mechanism of circulating DNA apoptosis and active DNA release","volume":"313","author":"Stroun","year":"2001","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.clinbiochem.2010.08.020","article-title":"Time of Sampling Is Crucial for Measurement of Cell-Free Plasma DNA Following Acute Aseptic Inflammation Induced by Exercise","volume":"43","author":"Fatouros","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41398-018-0264-x","article-title":"Cell-Free DNA Release under Psychosocial and Physical Stress Conditions","volume":"8","author":"Hummel","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1373\/clinchem.2007.092734","article-title":"The Origin of Circulating Free DNA","volume":"53","author":"Pretorius","year":"2007","journal-title":"Clin. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100087","DOI":"10.1016\/j.bdq.2019.100087","article-title":"The emerging role of cell-free DNA as a molecular marker for cancer management","volume":"17","author":"Bronkhorst","year":"2019","journal-title":"BioMol. Detect. Quantif."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1196\/annals.1368.026","article-title":"Circulating DNA and DNase Activity in Human Blood","volume":"1075","author":"Tamkovich","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/clinchem\/46.8.1078","article-title":"Genetic Analysis of DNA Excreted in Urine: A New Approach for Detecting Specific Genomic DNA Sequences from Cells Dying in an Organism","volume":"46","author":"Botezatu","year":"2000","journal-title":"Clin. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"16368","DOI":"10.1073\/pnas.0507904102","article-title":"Detection and Quantification of Mutations in the Plasma of Patients with Colorectal Tumors","volume":"102","author":"Diehl","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.gene.2016.06.033","article-title":"Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study","volume":"590","author":"Yao","year":"2016","journal-title":"Gene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1134\/S0006297906060010","article-title":"Proteins involved in binding and cellular uptake of nucleic acids","volume":"71","author":"Chelobanov","year":"2006","journal-title":"Biochem. Mosc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10555-016-9629-x","article-title":"Origins, structures, and functions of circulating DNA in oncology","volume":"35","author":"Thierry","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"ref_29","first-page":"1659","article-title":"DNA Fragments in the Blood Plasma of Cancer Patients: Quantitations and Evidence for Their Origin from Apoptotic and Necrotic Cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1182\/blood.V126.23.332.332","article-title":"Somatic Mutations Detected in Plasma Cell-Free DNA By Targeted Sequencing: Assessment of Liquid Biopsy in Primary Central Nervous System Lymphoma","volume":"126","author":"Fontanilles","year":"2015","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40478-019-0692-8","article-title":"Tumor Cell-Free DNA Detection in CSF for Primary CNS Lymphoma Diagnosis","volume":"7","author":"Rimelen","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2144\/btn-2018-0003","article-title":"Quantifying cell free DNA in urine: Comparison between commercial kits, impact of gender and inter-individual variation","volume":"64","author":"Streleckiene","year":"2018","journal-title":"BioTechniques"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3332\/ecancer.2017.717","article-title":"Circulating and Tissue Biomarkers in Early-Stage Non-Small","volume":"11","author":"Fumagalli","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Nair, N., Camacho-Vanegas, O., Rykunov, D., Dashkoff, M., Camacho, S.C., Schumacher, C.A., Irish, J.C., Harkins, T.T., Freeman, E., and Garcia, I. (2016). Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002206"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget Stool DNA Testing for Colorectal-Cancer Screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"65364","DOI":"10.18632\/oncotarget.11692","article-title":"Concordance between Genomic Alterations Assessed by Next-Generation Sequencing in Tumor Tissue or Circulating Cell-Free DNA","volume":"7","author":"Chae","year":"2016","journal-title":"Oncotarget"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.7150\/jca.15823","article-title":"Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity","volume":"7","author":"Huang","year":"2016","journal-title":"J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"40481","DOI":"10.18632\/oncotarget.9629","article-title":"Noninvasive Detection of Tumor-Associated Mutations from Circulating Cell-Free DNA in Hepatocellular Carcinoma Patients by Targeted Deep Sequencing","volume":"7","author":"Liao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e00125","DOI":"10.1016\/j.plabm.2019.e00125","article-title":"Comparison of Roche Cell-Free DNA collection Tubes to Streck Cell-Free DNA BCT s for sample stability using healthy volunteers","volume":"16","author":"Parackal","year":"2019","journal-title":"Pract. Lab. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.5858\/arpa.2018-0901-SA","article-title":"Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review","volume":"142","author":"Merker","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.clinbiochem.2016.03.012","article-title":"Comparative Analysis of Circulating Tumor DNA Stability In K3EDTA, Streck, and CellSave Blood Collection Tubes","volume":"49","author":"Kang","year":"2016","journal-title":"Clin. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cca.2013.05.022","article-title":"Circulating cell free DNA: Preanalytical considerations","volume":"424","author":"Rolet","year":"2013","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-Invasive Analysis of Acquired Resistance to Cancer Therapy by Sequencing of Plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3109\/10428194.2016.1139703","article-title":"Digital PCR for Quantification of Recurrent and Potentially Actionable Somatic Mutations in Circulating Free DNA from Patients with Diffuse Large B-Cell Lymphoma","volume":"57","author":"Camus","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","article-title":"Hodgkin Disease: Hodgkin and Reed-Sternberg Cells Picked from Histological Sections Show Clonal Immunoglobulin Gene Rearrangements and Appear to Be Derived from B Cells at Various Stages of Development","volume":"91","author":"Rajewsky","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1182\/blood-2008-11-189688","article-title":"Circulating Clonotypic B Cells in Classic Hodgkin Lymphoma","volume":"113","author":"Jones","year":"2009","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bjh.13349","article-title":"Detection of Classical Hodgkin Lymphoma Specific Sequence in Peripheral Blood Using a Next-Generation Sequencing Approach","volume":"169","author":"Oki","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1038\/sj.emboj.7601846","article-title":"Transcription of productive and nonproductive VDJ-recombined alleles after IgH allelic exclusion","volume":"26","author":"Daly","year":"2007","journal-title":"EMBO J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.3324\/haematol.2015.123612","article-title":"Somatic Mutations of Cell-Free Circulating DNA Detected by next-Generation Sequencing Reflect the Genetic Changes in Both Germinal Center B-Cell-like and Activated B-Cell-like Diffuse Large B-Cell Lymphomas at the Time of Diagnosis","volume":"100","author":"Bohers","year":"2015","journal-title":"Haematologica"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An Ultrasensitive Method for Quantitating Circulating Tumor DNA with Broad Patient Coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood.V126.23.130.130","article-title":"Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma","volume":"126","author":"Kurtz","year":"2015","journal-title":"Blood"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1182\/blood-2016-05-719641","article-title":"Diffuse Large B-Cell Lymphoma Genotyping on the Liquid Biopsy","volume":"129","author":"Rossi","year":"2017","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"364ra155","DOI":"10.1126\/scitranslmed.aai8545","article-title":"Distinct Biological Subtypes and Patterns of Genome Evolution in Lymphoma Revealed by Circulating Tumor DNA","volume":"8","author":"Scherer","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1093\/bioinformatics\/btaa053","article-title":"UMI-VarCal: A New UMI-Based Variant Caller That Efficiently Improves Low-Frequency Variant Detection in Paired-End Sequencing NGS Libraries","volume":"36","author":"Sater","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7150\/jca.13593","article-title":"Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma","volume":"7","author":"Primerano","year":"2016","journal-title":"J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nmeth.2027","article-title":"Digital PCR hits its stride","volume":"9","author":"Baker","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"313ra182","DOI":"10.1126\/scitranslmed.aac7551","article-title":"Analysis of ESR1 Mutation in Circulating Tumor DNA Demonstrates Evolution during Therapy for Metastatic Breast Cancer","volume":"7","author":"Schiavon","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1373\/clinchem.2013.206359","article-title":"Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients","volume":"59","author":"Taly","year":"2013","journal-title":"Clin. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Tone, A.A., McConechy, M.K., Yang, W., Ding, J., Yip, S., Kong, E., Wong, K.-K., Gershenson, D.M., Mackay, H., and Shah, S. (2014). Intratumoral Heterogeneity in a Minority of Ovarian Low-Grade Serous Carcinomas. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-982"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1078-0432.CCR-14-0983","article-title":"Clinical Relevance of KRAS-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy","volume":"21","author":"Pekin","year":"2015","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_61","first-page":"31","article-title":"Six Consecutive False Positive Cases from Cell-Free Fetal DNA Testing in a Single Referring Centre","volume":"8","author":"Dugo","year":"2014","journal-title":"J. Prenat. Med."},{"key":"ref_62","first-page":"107","article-title":"Current Challenges for Detection of Circulating Tumor Cells and Cell-Free Circulating Nucleic Acids, and Their Characterization in Non-Small Cell Lung Carcinoma Patients. What Is the Best Blood Substrate for Personalized Medicine?","volume":"2","author":"Ilie","year":"2014","journal-title":"Ann. Transl. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/annonc\/mdy513","article-title":"Biological Background of the Genomic Variations of Cf-DNA in Healthy Individuals","volume":"30","author":"Liu","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_64","first-page":"54399","article-title":"Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma","volume":"124","author":"Reichel","year":"2017","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal Transducer and Activator of Transcription 6 Is Frequently Activated in Hodgkin and Reed-Sternberg Cells of Hodgkin Lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41375-019-0541-6","article-title":"Genotyping Circulating Tumor DNA of Pediatric Hodgkin Lymphoma","volume":"34","author":"Desch","year":"2020","journal-title":"Leukemia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-018-0875-0","article-title":"Heterogeneous Mutation Pattern in Tumor Tissue and Circulating Tumor DNA Warrants Parallel NGS Panel Testing","volume":"17","author":"Guo","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1515\/cclm-2019-0142","article-title":"Analytical and Clinical Validation of a Novel Amplicon-Based NGS Assay for the Evaluation of Circulating Tumor DNA in Metastatic Colorectal Cancer Patients","volume":"57","author":"Wang","year":"2019","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2017.02.003","article-title":"Capturing tumor heterogeneity and clonal evolution in solid cancers using circulating tumor DNA analysis","volume":"174","author":"Perdigones","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"McDonough, S.J., Bhagwate, A., Sun, Z., Wang, C., Zschunke, M., Gorman, J.A., Kopp, K.J., and Cunningham, J.M. (2019). Use of FFPE-Derived DNA in next Generation Sequencing: DNA Extraction Methods. PLoS ONE, 14.","DOI":"10.1101\/521534"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin\u2019s Disease and Lymphocyte-Rich Classical Hodgkin\u2019s Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin\u2019s Disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2141.2002.03456.x","article-title":"Expression pattern of MUM1\/IRF4 in the spectrum of pathology of Hodgkin\u2019s disease","volume":"117","author":"Carbone","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/jcp.46.3.211","article-title":"Expression of C-Myc and Bcl-2 Oncogene Products in Reed-Sternberg Cells Independent of Presence of Epstein-Barr Virus","volume":"46","author":"Jiwa","year":"1993","journal-title":"J. Clin. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2012-05-428896","article-title":"Analyzing Primary Hodgkin and Reed-Sternberg Cells to Capture the Molecular and Cellular Pathogenesis of Classical Hodgkin Lymphoma","volume":"120","author":"Tiacci","year":"2012","journal-title":"Blood"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1038\/sj.onc.1205418","article-title":"Gene Expression Profiling Defines Molecular Subtypes of Classical Hodgkin\u2019s Disease","volume":"21","author":"Devilard","year":"2002","journal-title":"Oncogene"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal Gray Zone Lymphoma: The Missing Link between Classic Hodgkin\u2019s Lymphoma and Mediastinal Large B-Cell Lymphoma","volume":"29","author":"Pittaluga","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood-2018-04-791566","article-title":"How I treat primary mediastinal B-cell lymphoma","volume":"132","year":"2018","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.24451","article-title":"Recurrent Mutations of the Exportin 1 Gene (XPO1) and Their Impact on Selective Inhibitor of Nuclear Export Compounds Sensitivity in Primary Mediastinal B-Cell Lymphoma: XPO1 Mutations in Primary Mediastinal B-Cell Lymphoma","volume":"91","author":"Jardin","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2014-05-575092","article-title":"Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: Do they require a unique therapeutic approach?","volume":"125","author":"Dunleavy","year":"2015","journal-title":"Blood"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11899-012-0130-5","article-title":"Gray zone lymphoma: Better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?","volume":"7","author":"Dunleavy","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41379-019-0428-0","article-title":"Diagnostic Utility of STAT6YE361 Expression in Classical Hodgkin Lymphoma and Related Entities","volume":"33","author":"Huh","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7150\/jca.6226","article-title":"Plasma Cell-Free DNA in Paediatric Lymphomas","volume":"4","author":"Mussolin","year":"2013","journal-title":"J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41408-018-0111-6","article-title":"Non-Invasive Monitoring of Diffuse Large B-Cell Lymphoma by Cell-Free DNA High-Throughput Targeted Sequencing: Analysis of a Prospective Cohort","volume":"8","author":"Bohers","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/bloodadvances.2017015164","article-title":"Total Metabolic Tumor Volume, Circulating Tumor Cells, Cell-Free DNA: Distinct Prognostic Value in Follicular Lymphoma","volume":"2","author":"Dupuis","year":"2018","journal-title":"Blood Adv."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13550-020-00717-y","article-title":"Correlations between Baseline 18F-FDG PET Tumour Parameters and Circulating DNA in Diffuse Large B Cell Lymphoma and Hodgkin Lymphoma","volume":"10","author":"Decazes","year":"2020","journal-title":"EJNMMI Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s11899-009-0026-1","article-title":"The host-tumor interface in B-cell non-Hodgkin lymphoma: A new world to investigate","volume":"4","author":"Rachinel","year":"2009","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11548-019-02049-2","article-title":"Detection and segmentation of lymphomas in 3D PET images via clustering with entropy-based optimization strategy","volume":"14","author":"Hu","year":"2019","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","article-title":"Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma","volume":"36","author":"Kurtz","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1158\/0008-5472.CAN-18-0887","article-title":"Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring","volume":"78","author":"Best","year":"2018","journal-title":"Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/jth.13720","article-title":"Platelet RNA as a circulating biomarker trove for cancer diagnostics","volume":"15","author":"Best","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood-2018-12-852830","article-title":"Tumor-educated platelets","volume":"133","author":"Wurdinger","year":"2019","journal-title":"Blood"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/s41596-019-0139-5","article-title":"RNA sequencing and swarm intelligence\u2013enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA","volume":"14","author":"Best","year":"2019","journal-title":"Nat. Protoc."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1586\/14737159.2014.943193","article-title":"Extracellular vesicles as a platform for \u2018liquid biopsy\u2019 in glioblastoma patients","volume":"14","author":"Steinberg","year":"2014","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.clinbiochem.2013.10.020","article-title":"Comparison of Serum Exosome Isolation Methods for MicroRNA Profiling","volume":"47","author":"Rekker","year":"2014","journal-title":"Clin. Biochem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ymeth.2012.01.002","article-title":"Comparison of Ultracentrifugation, Density Gradient Separation, and Immunoaffinity Capture Methods for Isolating Human Colon Cancer Cell Line LIM1863-Derived Exosomes","volume":"56","author":"Tauro","year":"2012","journal-title":"Methods"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1038\/mtna.2013.28","article-title":"BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 MRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles","volume":"2","author":"Chen","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/3\/207\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:31:33Z","timestamp":1760160693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/3\/207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":97,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["ph14030207"],"URL":"https:\/\/doi.org\/10.3390\/ph14030207","relation":{},"ISSN":["1424-8247"],"issn-type":[{"type":"electronic","value":"1424-8247"}],"subject":[],"published":{"date-parts":[[2021,3,2]]}}}